We further documented the on-target effects of PTC-209 in MM by showing that other PRC1 subunits i.e. CBX-7 and, most importantly, the E3 ubiquitin ligase RING1B were not affected by the PTC-209 treatment (Figure 2B). Here, CBX7 is linked to Miyoshi myopathy.